{"id":4579,"date":"2025-06-13T23:00:06","date_gmt":"2025-06-13T23:00:06","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/06\/13\/biotech-news-cdc-vaccine-panel-moderna-rsv-vaccine-hhs-drug-pricing-the-readout\/"},"modified":"2025-06-13T23:00:06","modified_gmt":"2025-06-13T23:00:06","slug":"biotech-news-cdc-vaccine-panel-moderna-rsv-vaccine-hhs-drug-pricing-the-readout","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/06\/13\/biotech-news-cdc-vaccine-panel-moderna-rsv-vaccine-hhs-drug-pricing-the-readout\/","title":{"rendered":"STAT+: HHS tries pushing pharma to the negotiating table"},"content":{"rendered":"

STAT+: HHS tries pushing pharma to the negotiating table
\n \t

\n
<\/BR>
\n
\n \t

\n
<\/BR><\/p>\n

\n

Want to stay on top of the science and politics driving biotech today?\u00a0Sign up<\/a>\u00a0to get our biotech newsletter in your inbox.<\/em><\/p>\n

Good morning. Today, we\u2019re hearing more about President Trump\u2019s \u201cmost-favored nation\u201d plan for drug pricing, Recursion\u2019s case for why the company laid off 20% of its staff, and more.<\/p>\n

HHS tries pushing\u00a0pharma to the negotiating table<\/h2>\n

The Trump administration is pressuring pharmaceutical companies to negotiate drug prices down to levels seen in other wealthy nations, invoking a \u201cmost-favored nation\u201d clause as leverage. While industry executives await specifics on which drugs and price targets could be\u00a0in play, the Department of Health and Human Services is insisting companies already have the guidance they need, STAT\u2019s Daniel Payne reports.<\/p>\n

Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n

\t

\n
<\/BR>
\n Meghana Keshavan
\n \t

\n
<\/BR>
\nGo to statnews<\/a>
\n \t

\n
<\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"

STAT+: HHS tries pushing pharma to the negotiating table Want to stay on top of the science and politics driving biotech today?\u00a0Sign up\u00a0to get our biotech newsletter in your inbox. Good morning. Today, we\u2019re hearing more about President Trump\u2019s \u201cmost-favored nation\u201d plan for drug pricing, Recursion\u2019s case for why the company laid off 20% of […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2194,2154,58,2208,2209,2176,858,2207],"tags":[2150],"class_list":["post-4579","post","type-post","status-publish","format-standard","hentry","category-biotech","category-biotechnology","category-business","category-drug-development","category-drug-prices","category-pharma","category-research","category-the-readout","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/4579"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=4579"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/4579\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=4579"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=4579"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=4579"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}